학술논문
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
Document Type
Article
Author
Schönherr, H.; Taylor, A.M.; Casaletto, J.B.; Touré, B.B.; Moustakas, D.T.; Hudson, B.M.; Valverde, R.; Zhao, S.; O’Hearn, P.J.; Foster, L.; Lescarbeau, A.; Kurukulasuriya, R.; Gerami-Moayed, N.; Maglic, D.; Bruderek, K.; Naik, G.; Gunaydin, H.; Mader, M.M.; Boezio, A.A.; McLean, T.H.; Watters, J.; Bergstrom, D.A.; Ayaz, P.; Sharon, D.A.; Garfinkle, S.; Giordanetto, F.; Shaw, D.E.; Chen, R.; Wang, Y.
Source
In: Proceedings of the National Academy of Sciences of the United States of America . (Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(6))
Subject
Language
English
ISSN
10916490
00278424
00278424